EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first ...

A pancreatic cancer diagnosis is almost always serious, but symptoms often aren’t noticeable until the disease is in the ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Immuneering Corporation (NASDAQ:IMRX) revealed data updates from three pancreatic cancer arms of its ongoing Phase 2a trial ...

With limited treatment options available for patients with PDAC, the EMA Orphan Drug Designation and FDA Orphan Drug Designation granted to elraglusib for the same indication reflect elraglusib’s ...

Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company, made waves in the stock market this week, with its stock price surging a staggering 133.90% to $5.52 during Tuesday’s ...

Colorado University’s Eduardo Davila found that DNA-PK inhibitors stop inhibition of detectable molecules and also increase ...

TriSalus Life Sciences, Inc., , an oncology company dedicated to improving outcomes for patients with solid tumors by integrating our innovative delivery technology with standard-of-care therapies, ...

During pregnancy, some expectant mothers choose to have blood tests to screen for fetal conditions like Down syndrome. On ...

Researchers tested more than 300 foods sold at restaurant chains and in grocery stores across America for two microscopic ...